Comment: Oral Varenicline for Smoking Cessation

Abstract

Get full access to this article

View all access options for this article.

References

Zierler-Brown

Kyle

. Oral varenicline for smoking cessation. Ann Pharmacother 2007;41:95–9. Epub 26 Dec 2006. DOI 10.1345/aph.1H310

Henningfield

Keenan

. Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 1993: 61;743–50.

Prescribing instructions. Chanitix (varenicline). New York: Pfizer, May 2006.

Gonzales

Rennard

Nides

. for the Varenicline Phase 3 Study Group. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006;296:47–55.

Jorenby

Hays

Rigotti

. for the Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296:56–63.

Molander

Hansson

Lunell

. Pharmacokinetics of nicotine in healthy elderly people. Clin Pharmacol Ther 2001;69:57–65.